Immunotherapy for Solid Malignancies, An Issue of Surgical Oncology Clinics of North America, 1st Edition
Author :
Alfred E. Chang
This issue of Surgical Oncology Clinics of North America focuses on Immunotherapy for Solid Malignancies and is edited by Dr. Alfred E. Chang. Articles will include: Current immunotherapy practices for melanoma; Immunotherapy for ovarian cancer; Vacc ...view more
This issue of Surgical Oncology Clinics of North America focuses on Immunotherapy for Solid Malignancies and is edited by Dr. Alfred E. Chang. Articles will include: Current immunotherapy practices for melanoma; Immunotherapy for ovarian cancer; Vaccines therapies for melanoma; Vaccine therapies for breast cancer; Induced pleuripotent T cells for adoptive immunotherapy; Future research goals in immunotherapy; Oncolytic immunotherapy; Adoptive T cell therapy for solid malignancies; Checkpoint inhibition immunotherapy; Toxicities of immunotherapy agents; Immunologic targeting of cancer stem cells; Role of surgery in combination with immunotherapy; and more!
This issue of Surgical Oncology Clinics of North America focuses on Immunotherapy for Solid Malignancies and is edited by Dr. Alfred E. Chang. Articles will include: Current immunotherapy practices for melanoma; Immunotherapy for ovarian cancer; Vaccines therapies for melanoma; Vaccine therapies for breast cancer; Induced pleuripotent T cells for adoptive immunotherapy; Future research goals in immunotherapy; Oncolytic immunotherapy; Adoptive T cell therapy for solid malignancies; Checkpoint inhibition immunotherapy; Toxicities of immunotherapy agents; Immunologic targeting of cancer stem cells; Role of surgery in combination with immunotherapy; and more!
Author Information
By Alfred E. Chang, MD, Hugh Cabot Professor of Surgery, Division of Surgical Oncology, University of Michigan Comprehensive Cancer CenterAnn Arbor, MI
https://www.us.elsevierhealth.com/immunotherapy-for-solid-malignancies-an-issue-of-surgical-oncology-clinics-of-north-america-9780323678254.html3928Immunotherapy for Solid Malignancies, An Issue of Surgical Oncology Clinics of North Americahttps://www.us.elsevierhealth.com/media/catalog/product/9/7/9780323678254.jpg81.74108.99USDInStock/Medicine/General Surgery/Clinics/Clinics474388725525504113841826925145120This issue of Surgical Oncology Clinics of North America focuses on Immunotherapy for Solid Malignancies and is edited by Dr. Alfred E. Chang. Articles will include: Current immunotherapy practices for melanoma; Immunotherapy for ovarian cancer; Vaccines therapies for melanoma; Vaccine therapies for breast cancer; Induced pleuripotent T cells for adoptive immunotherapy; Future research goals in immunotherapy; Oncolytic immunotherapy; Adoptive T cell therapy for solid malignancies; Checkpoint inhibition immunotherapy; Toxicities of immunotherapy agents; Immunologic targeting of cancer stem cells; Role of surgery in combination with immunotherapy; and more! This issue of Surgical Oncology Clinics of North America focuses on Immunotherapy for Solid Malignancies and is edited by Dr. Alfred E. Chang. Articles will include: Current immunotherapy practices for melanoma; Immunotherapy for ovarian cancer; Vaccines therapies for melanoma; Vaccine therapies for breast cancer; Induced pleuripotent T cells for adoptive immunotherapy; Future research goals in immunotherapy; Oncolytic immunotherapy; Adoptive T cell therapy for solid malignancies; Checkpoint inhibition immunotherapy; Toxicities of immunotherapy agents; Immunologic targeting of cancer stem cells; Role of surgery in combination with immunotherapy; and more!00add-to-cart97803236782542019ProfessionalBy Alfred E. Chang, MD20191Book152w x 229h (6.00" x 9.00")Elsevier0May 19, 2019IN STOCK - This may take up to 5 business days to shipBy <STRONG>Alfred E. Chang</STRONG>, MD, Hugh Cabot Professor of Surgery, Division of Surgical Oncology, University of Michigan Comprehensive Cancer CenterAnn Arbor, MIClinicsClinicsThe Clinics: SurgeryNoNoNoNoPlease SelectPlease SelectPlease Select
